| Molecular Interaction Atlas (MIA) |
|
| Indication(s) of Mecamylamine |
| Disease Entry |
ICD 11 |
Status |
REF |
| Essential hypertension |
BA00
|
Approved |
[2] |
|
|
|
Mecamylamine Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Nicotinic acetylcholine receptor (nAChR)
|
TTJSZTB
|
NOUNIPROTAC
|
Antagonist
|
[4] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Mecamylamine Interacts with 5 DOT Molecule(s)
| DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
|
Receptor-type tyrosine-protein phosphatase alpha (PTPRA)
|
OTZA82J1
|
PTPRA_HUMAN
|
Decreases Expression
|
[3] |
|
Fasciculation and elongation protein zeta-1 (FEZ1)
|
OTWCXPRE
|
FEZ1_HUMAN
|
Decreases Expression
|
[3] |
|
Lipopolysaccharide-induced tumor necrosis factor-alpha factor (LITAF)
|
OTT5JX1F
|
LITAF_HUMAN
|
Decreases Expression
|
[3] |
|
Stress-induced-phosphoprotein 1 (STIP1)
|
OT7TXLOX
|
STIP1_HUMAN
|
Decreases Expression
|
[5] |
|
Golgin subfamily A member 4 (GOLGA4)
|
OTCMEHNJ
|
GOGA4_HUMAN
|
Increases Expression
|
[5] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
| Indication(s) of Mebutamate |
| Disease Entry |
ICD 11 |
Status |
REF |
| Anxiety disorder |
6B00-6B0Z
|
Approved |
[2] |
|
|
|
Mebutamate Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
GABA(A) receptor gamma-3 (GABRG3)
|
TTEX6LM
|
GBRG3_HUMAN
|
Modulator
|
[6] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
|
|
|
|
|
|